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The oxidative metabolism of sparteine in 
the Cuna Amerindians of Panama: 
Absence of evidence for 
deficient metabolizers 
Sparteine sulfate (50 mg) was administered to 170 Cuna Amerindians, 142 of whom were unrelated, 
and the drug and its dehydrometabolites were determined in the 0- to 12-hour urine samples. The log 
of the metabolic ratio was unimodally, but not normally, distributed and showed the following values: 
mean —0.21 ± 0.26, median — 0.24, limits —0.73 and 0.76, skewness 1.00, and kurtosis 4.95. On the 
basis of these results, it can be concluded that there are no deficient metabolizes in the Cuna sample 
population studied. However, the similarity of the skewness found between the Cuna sample population 
r's studied and the extensive Canadian white group, as well as an inflection point at 6.3 13 in the former's 
probit plot, suggests the existence of at least two subgroups congregating within the same single mode 
in the frequency distribution curve. The use of the inflection point is discussed thoroughly, concluding 
that although it does not allow exclusion of the existence of genotypically different subgroups, the 
limitations of the data do not permit its use to determine the number of heterozygotes and thus the 
existence of polymorphism. The possibility of an isozyme variant, consistent with the general genetic 
structure of Amerindians, as suggested by the coexistence of two subgroups within the unimodal curve, 
is entertained. (Crary PHAitstAcot. THER 1988;43:456-65.) 
T. D. Arias, Ph.D., L. F. Jorge, M.Sc., D. Lee, M.D., IL Barrantes, Ph.D., and 
T. Inaba, Ph.D. Panama, Rep:Wit-a de Panamd, San Jose; Costa Rica, and Toronto, Canadp 
The oxidative biotransformation of sparteine has 
been associated in whites with the metabolism of 
debrisoquin and some clinically useful drugs such as 
certain p-blockcrs, some tricyclic antidepressants, and 
others." In addition to whites,' the genetic rx)lymor-
Otism of the metabolism of sparteine has been studied 
---` acks5 and Japanese' (Inaba T, Kalow W, unpub-
lis.ed results). 
To our knowledge no previous studies of the oxi-
dative biotransformation of sparteine in Amerindians 
and populations mixed with them. about 30 and 100 
million, respectively,'" have been carried out. This ap- 
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parent neglect has occurred in spite of the relevance of 
this pathway and the demographic importance of these 
populations in Latin America. We therefore wish to 
confirm and expand our preliminary work, which we 
have recently described.19-" 
For these studies we selected the Cuna Amerindian 
group of Panama because it is one of the most populous 
(about 55,000) of the genetically homogeneous Amer-
indian groups."' 
METHODS 
Two hundred three Cuna volunteers from Panama 
were selected for the study. The subjects were inhab-
itants of Panama City and the Amerindian villages of 
Rio Azticar (Comarca de San Bias) and Kuna-Nega 
(Province of Panama). They were advised in Spanish 
or the Cuna language of their rights, as set down in the 
Helsinki Declaration, and were specifically requested 
not to drink any alcoholic beverages during the study. 
informed consent forms were signed and physical 
examinations and interviews were performed. Only 
healthy subjects of Cuna ancestry, as revealed through 
anamnesis. anthropometric criteria, and medical ex- 
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amination, who were not taking any drugs were ac-
cepted for the study. A preliminary selection was car-
ried out to exclude those subjects who were related in 
the fourth degree of consanguinity or closer. However, 
in certain cases in which potential problems of com-
pliance were expected, the test drug was administered 
to more than one relative. 
Each volunteer took 50 mg sparteine sulfate at 6. PM 
after emptying the bladder and before dinner. The urine 
was collected overnight for 12 hours and, when the 
collection was made in the villages, the aliquots were 
kept on ice until taken to Panama City, where they were 
stored at — 20° C. . 
After analysis of the urine, 28 subjects were elirni-
i,^ qted because of the consanguinity exclusion criterion 
.d 20 because of noncompliance, suspected compli-
ance problems based on undetectable or very low 
amounts of recovered drug in the urine, or, in certain 
cases, because of abnormally low creatinine elimina-
tion. Another 12 subjects were eliminated for other 
reasons not related to the results of the analyses. We 
thus report the results obtained from only 142 subjects 
(77 males and 65 females; ages 16 to 70 years old; 
mean 35 years). 
The samples were assayed according to a slight mod-
ification of the method of Inaba et al.,' in which meth-
ylene chloride was substituted by toluene to decrease 
the risk of damage to the.nitrogen-phosphorus detector, 
as warned by its manufacturer (Varian Associates, Inc., 
Palo Alto-, 
Sur/is/leaf analysis. Differences between groups of 
the population, as classified by the place of collection 
of the samples, were evaluated by the Mann-Whitney 
(nonparametric) test. The distributions of the recov-
of the drug, its 2- and 5-dehydrometabolites, and 
the metabolic ratio (molar sparteine/dehydrosparteines) 
were analyzed by the e goodness-of-fit test. 
Because in certain cases this test is not able to detect 
certain departures from normality" and we also wished 
to quantify them for comparisons of groups and pop-
ulations, skewness and kurtosis of the various popu-
lations disaicsPd were determined by the commercially 
available statistics program for microcomputers, Abstat 
(release 4, Anderson-Bell Co., Canon City, Colo.). 
A measure of the amount of skewness in the popu-
lation is given by the quantity called "the third moment 
about the mean." If the sample comes from a normal 
distribution, the coefficient of skewness is approxi-
mately normally distributed with a mean of 0. In pop-
ulations with positive skewness the higher tail is ex-
tended, whereas in populations with negative skewness 
an extension is seen for the lower tail. A measure of 
142 Cunas 
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Fig. 1. Frequency histograms of the LMR (log SPID1-1) of 
142 unrelated Cuna Amerindians (filled bars) from Panama 
and 199 unrelated Canadian whites (Can. Canc.). The Ca-
nadian data were pooled from published and unpublished 
studies by Inaba et al." and are represented by the hatched 
bars. 
kurtosis has a value of 3 for the normal distribution, 
whereas flat-topped or platykurtic distributions show 
values smaller than 3, and peaked distributions, also 
known as leptokurtic, have values greater than 3.1" 
Evaluation of the skewness that might characterize 
the distribution curve of different experimental indexes 
among various groups and populations provides a re-
fined tool, so far ignored in these studies, to detect the 
possible existence of subgroups that are not different 
enough to educe different modes and yet are large 
enough to introduce deviations from normality in those 
cases in which a single mode is found. Of particular 
significance would be the manifestation of positive 
skewness in the distribution of metabolic ratios, which 
could suggest the existence of variants with interme-
diate activities between those corresponding to exten-
sive and those corresponding to poor metabolizers. 
RESULTS 
Data for each Cuna subject are presented in Table I: 
sex, urinary recovery (0- to 12-hour) of sparteine, 
2- and 5-dehydrosparteine, total drug, metabolic ratio, 
and log,n of this ratio (LMR). No significant differences 
between the means were found (Mann-Whitney U test, 
p > 0.05) when the amount of drug and metabolites 
recovered from the various groups were compared with 
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Table 1. Subject data for urinary elimination of sparteine and its metabolites in 142 Cuna 	 • 
Amerindians of Panama 
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Subject 
No. 
2 
3 
4 
7 
8 
9 
10 
11 
12 
15 
16 
18 
21 
22 
rTh 23 
26 
28 
29 
30 
32 
33 
37 
38 
39 
40 
41 
42 
44 
48 
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56 
57 
58 
-59 
61 
64 
65 
69 
71 
72 
75 
76 
77 
78 
79 
80 
81 
82 
83 
85 
86 
88 
89 
91 
92 
SP 
(90 
DH 
(%) 
Sum 
(SP .+ DH) 
Metabolic ratio 
(SPIDH) 
Log metabolic 
ratio 
5.51 14.98 20.49 0.37 -0.43 
36.34 76.84 113.18 0.47 -0.33 
16.20 72.13 88.33 0.22 -0.65 
24.51 49.45 73.96 0.50 -0.30 
32.52 49.44 81.96 0.66 -0.18 
18.24 74.72 92.96 0.24 -0.61 
6.48 35.17 41.65 0.18 -0_73 
28.54 24.60 53.14 1.16 0.06 
23.67 36.69 60.36 0.65 -0.19 
23.36 40.69 64.05 0.57 -0.24 
23.73 55.74 79.47 0.43 -0.37 
22.65 21.22 43.87 1.07 0.03 
19.60 21.93 41.54 0.89 -0.05 
27.17 25.93 53.09 1.05 0.02 
28.89 41.01 69.91 0.70 -0.15 
17.82 14.84 32.66 1.20 . 0.08 
19.99 32.87 52.86 0.61 --0.22 
.12.24 16.51 28.75 0.74 --0_13 
20.09 53.08 73.17 0.38 -0.42 
14.25 27.12 41.37 0.53 -0.28 
11.17 30.63 41.80 0.36 -0.44 
1741 45.42 62.83 0.38 -0.42 
5.16 12.55 17.71 0.41 -0.39 
7.50 30.75 38.25 0.24 -0.61 
36.31 29.07 65.38 1.25 0.10 
22.42 31.94 54.37 0.70 -0.15 
17.60 34.63 52.23 0.51 -0.29 
15.68 37.11 52.79 0.42 -0.37 
_ 28.73 48.14 76.87 0.60  -0.22 
24.35 4.2.38 66.72 0.57 -0.24 
4.30 13.80 18.10 0.31 -0.51 
3.20 11.40 14.60 0.28 -0.55 
2.30 8.50 10.80 0.27 -0.57 
6.20 22.40 28.60 0.28 -0.56 
11.72 15.97 27.68 0:73 -0.13 
7.41 7.78 15.19 0.95 -0.02 
9.03 38.65 47.68 0.23 -0.63 
13.56 33.98 47.54 0.40 -0.40 
8.38 28.79 37.17 0.29 -0.54 
19.64 17.15 36.79 1.15 0.06 
17.83 29.36 47.19 0.61 -0.22 
10.92 23.29 34.20 0.47 -0_33 
3.35 4.37 7.72 0.77 -0.11 
25.98 26.87 52.84 0.97 -0.01 
29.91 28.20 58.11 1.06 0.03 
18.22 41.34 59.56 0.44 -0.36 
11.84 18.37 30.21 0.64 -0.19 
38.60 26.62 65.23 1.45 0.16 
9.59 14.33 23.92 0.67 - 0.17 
3.63 7.25 10.89 0.50 - 0.30 
13.44 35.73 49.17 0.38 - 0.42 
4.68 14.81 19.49 0.32 - 0.50 
16.71 28.01 44.72 0.60 - 0.22 
50.23 13.00 63.23 3.86 0.59 
19.67 7.39 27.06 2.66 0.43 
13.53 26.62 40.15 0.51 - 0.29 
SP, sparteine: DH. debydrosparteine. 
Subject Nos. 1.82 and 168-178 were from Panama City: subject Nos. 83-167 were from Rio Arucar: subtec< Nos. 179-203 were front Kuna-Nega. 
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Table I. -Oant'd 
SP 
(%) 
DH 
(%) 
Sum 
(SP + 
Metabolic ratio 
) 	 (SPIDH) 
Log metabolic 
ratio 
6.00 12.51 18.52 0.48 -0.32 
9.29 17.57 26.85 0.53 -0.28 
6.43 30.16 36.60 0.21 -0.67 
12.48 31.82 44.31 0.39 -0.41 
13.47 19.75 3122 0.68 -0.17 
12.86 15.66 28.52 0.82 -0.09 
11.92 22.97 34.90 0.52 -0.28 
7.80 23.80 31.60 0.33 -0.48 , 
10.50 14.04 24.54 0.75 -0.13 
6.43 10.05 16.48 0.64 -0.19 
29.86 32.32 62.18 0.92 -0.03 
20.56 30.39 50.96 0.68 -0.17 
17.31 32.55 49.86 0.53 -0.27 
23.26 34.19 57.45 0.68 -0.17 
13.90 32.28 46.18 0.43 -0.3.7 
35.40 41.39 76.78 0.86 -0.07 
29.82 21.80 51.61 1.37 0.14 
29.40 27.02 56.41 1.09 0.04 
15.25 44.14 59.40 0.35 -0.46 
21.50 26.70 48.21 0.81 -0.09 
10.66 47.60 58.26 0.22 -0.65 
16.56 22.33 38.89 0.74 -0.13 
21.40 20.83 42.22 1.03 0.01 
6.48 9.11 15.58 0.71 -0.15 
26.83 4.71 31.54 5.70 0.76 
20.09 48.64 68.73 0.41 -0.38 
19.48 39.51 58.99 0.49 -0.31 
28.69 40.13 68.82 0.71 -0.15 
22.58 20.37 42.95 1.11 0.04 
13.07 3.02 16.09 4.32 0.64 
13.38 36.47 49.85 0.37 -0.44 
32.95 34.40 67.35 0.96 -0.02 
9.95 11.36 21.31 0.88 -0.06 
18.44 59.54 77.98 0.31 -0.51 
19.09 46.05 65.14 0.41 -0.38 
9.91 8.39 18.30 - 1.18 0.07 
4.13 9.87 14.01 0.42 -0.38 
10.88 5.01 15.89 2.17 0.34 
15.62 40.21 55.83 0.39 -0.41 
23.12 25.77 48.89 0.90 -0.05 
12.75 7.68 20.42 1.66 0.22 
8.29 17.73 26.01 0.47 -0.33 
7.36 19.60 26.95 0.38 -0.43 
6.84 14.84 21.68 0.46 -0.34 
19.80 27.40 47.20 0.72 -0.14 
20.51 36.20 56.71 0.57 -0.25 
19.57 33.98 53.55 0.58 -0.24 
5.74 15.99 21.73 0.36 - 0.45 
8.68 12.75 21.43 0.68 - 0.17 
27.01 14.62 41.64 1.85 0.27 
30.97 29.09 60.06 1.06 0.03 
33.48 18.90 52.37 1.77 0.25 
5.12 10.61 15.72 0.48 - 0.32 
22.82 39.35 62.18 0.58 - 0.74 
13.44 19.13 32.57 0.70 -0.15 
9.62 19.09 28.71 0.50 - 0.30 
31.11 32.23 63.33 0.97 - 0.02 
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SP 
(%) 
DH 
(%) 
Sum 
(SP + DH ) 
Metabolic ratio 
(SPIDH) 
Log metabolic 
ratio 
2_39 6.56 8.95 0.36 -0.44 
25.00 40.83 65.83 0.61 -0.21 
9.02 21.20 30.22 0.43 -0.37 
20.17 44.84 65.01 0.45 -0.35 
7.40 13.36 20.76 0.55 -0.26 
9.88 17.12 27.00 0.58 -0.24 
6.95 13.71 20.66 0.5! -0.29 
15.78 22.92 38.70 0.69 -0.16 
30.65 32.81 63.46 0.93 -0,03 
26.33 33.27 59.60 0.79 -0.10 
24.84 35.30 60.14 0.70 -0.15 
16.89 21.96 38.85 0.77 -0.11 
15.89 39.84 55.73 0.40 -0.40 
13.25 2939 43.03 0.44 -0.35 
7.16 13.08 20.24 0.55 -0.26 
15.03 33.51 48.55 0.45 -0.35 
9.66 13.95 23.61 0.69 -0A6 
21.09 29.42 50.50 0.72 -0.14 
8.64 19.15 27.79 . 0.45 -0.35 
22.97 7.69 30.66 2.99 0.48 
7.37 29.39 36.76 0.25 -0.60 
6.00 13.93 19.93 0.43 -0.37 
4.77 7.90 12.67 0.60 -0.22 
27.20 25.94 53.14 1.05 0.02 
5.75 14.84 20.59 0.39 -0.41 
7.22 14.30 21.52 0.51 -0.30 
4.75 10.22 14.97 0.46 -0.33 
17.68 38.80 56.48 0.46 -0_34 
26.04 44.01 70.05 0.59 -0.23 
those of Rio Azticar, nor were there differences when 
the metabolic ratios were compared. Their descriptive 
statistics are presented in Table 11 and the results are 
grouped according to the place of collection as well. 
Beevse the data were independent of the place, 
poc, 	 data were used for the subsequent calculations. 
In those 142 subjects, total urinary recoveries (0- to 12-
hour) of sparteine, 2- and 5-dehydrosparteine, and the 
total percentage of drug excreted were 16.6% ± 9.3% 
(SD), 26.6% ± 14.4%, and 43.3% ± 20.3%, respec-
tively. The values of the metabolic ratio ranged widely, 
with a mean of 0.76 ± 0.72 (LMR = - 0.21 
0.26) and a median value of 0.58 (LMR = - 0.24); 
limits were 0.18 and 5.70 (LMR = -0.73 and 0.76) 
with a range of 5.52 (LMR = 1.49). 
The frequency distribution histogram of LMR is 
shown in Fig. 1 and its probit plot in Fig. 2. Absence 
of an antimode in Fig. 1, as well as the general linearity 
in the probit plot, with the exception of an inflection 
point at 6.3 probit U, indicates the absence of a group 
in the Cuna population that could be associated with  
the presence of deficient metabolizers. Furthermore, 
none of the 28 subjects who were excluded because of 
the consanguinity criterion had a metabolic ratio higher 
than the mean value 0.76. Among this total of 170 
observations, there were no deficient metabolizers of 
sparteine. 
In Fig. 1 the LMR of whites living in Toronto, Can-
ada, were plotted alongside; in this population, using 
an antimode of 1.3, seven subjects (3.5%) are classified 
as deficient metabolizers. The Cuna and white extensive 
metabolizers exhibited similar distribution histograms_ 
In Fig. 2 slight deviations from the straight line in the 
upper range of probit values, in both the Cuna and 
Ghanaian subjects. are also observed. However, these 
departures from normality are not as marked as those 
observed in multimodal distributions and are likely as-
sociated with certain departures of normality com-
mented on below. 
The results of the x' goodness-of-fit test rejected the 
hypothesis, at acceptable levels of significance (a = 
0.05). that the LMR of sparteine follows a normal dis- 
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Table H. Summary of the urine recovery of sparteine and 2- and 5-dehydrosparteines in 142 unrelated Cuna 
Amerindians from three places 
Place of 
collection Statistics Sparteine 
• Dehvdrosparteine 
Total drug 
(SP + DH ) 
LMR 
(SPIDH) 
Panama city Mean t  SD 17.1 ± 9.6 30.1 ± 	 16.1 47.2 ± 22.8* -0.26 ± 0.21* 
(n -= 60) Median 17.5 28.5 47.4 - 0.25 
Rio Azucar Mean ± SD 16.8 ± 9.3 24.3 ± 12.8 41.1 	 ± 	 18.1 -0.16 ± 0.29 
(n = 62) Median 17.5 22.7 42.6 - 0.18 
Chivo-Chivo Mean ± SD 14.4 ± 8.0 23.8 ± 	 11.5 38.2 ± 17.6* -0.23 ± 0.22* 
(n = 20) Median 14.1 24.0 37.8 -0.28 
Total population Mean ± SD 16.6 ± 9.3 26.7 ± 14.4 43.3 -±.- 20.3 -0.21 ± 0.26 
(a = 142) Median 15.7 26.3 43.0 0.24 
Skewnesst -0.55T -0.67$ -0.63$ 1.00-1 
Kurtosisf 2.66§ 3.23* 2.691  4.950 
SP, sparteine; DH, dehydrosperteine. 
significant &Zeno= (p > 0.05) compared with Rio Azucta by Mano-Whitoey U test. 
Li* values (e.g. fog [SP])  were used- 
tHegarive skewness (<1%. lower tail). 
iNo significant kurtosis (>5%). 
Patitive kurtosis (<195, patted distribution). 
tribution, thus confirming the observed nature of the 
corresponding probit plot. This departure from nor-
mality is described in Table Ill in terms of skewness 
and kurtosis for the Cana and other populations dis-
cussed elsewhere. - 
In addition to the descriptive statistics of the Cuna 
data, we have included in Table III, for comparison 
purposes, similar data for Ghanaian. blacks and Cana-
dian whites. Because we wished to examine  in closer 
detail the nonwhite populations, which lack deficient 
metabolizers, and compare them with the group of 
white extensive metabolizers, we have presented their 
descriptive statistics in separate columns, one for the 
role white population and another for the group of 
.ensive metabolizers. 
Inspection of Table III reveals that the distribution 
curves for all three populations showed positive skew-
ness, as well as leptokurtic character, with a maximum 
value in Canadian whites, as expected by the presence 
of two groups of metabolizers. Similar values are shown 
for Cuna Amerindians and white extensive metabo-
lizers and a minimum value for Ghanaian blacks. The 
departures from normality found in these black sub-
jects had already been reported by Eichelbaum and 
Woolhouse 
DISCUSSION 
Absence of deficient metabolizers in the Cuna sam-
ple population studied. Because the present study was 
the first to evaluate oxidative metabolism in any Amer-
indian group, particular attention was paid to the ethnic 
homogeneity and general phylogenic relations of the  
population studied. Results of genetic studies carried 
out simultaneously with this one and to be published 
elsewhere (Neel N, personal communication) confirm 
our original expectations arising from earlier ob-
servationsim": the Cuna population of Rio Azticar is 
characterized by a low racial admixture (i.e., <1%). 
It was also estimated that the Cuna's genetic divergence 
with neighboring Amerindian groups occurred at least 
3000 to 5000years ago. 	 - 	 , 
For the above reason we have used the community 
of Rio Axil= as the reference population in comparing 
data obtained in the other two locations: Kuna Nega 
and Panama City. Because the results of samples col-
lected in other communities were not significantly dif-
ferent from those of the reference population, we corn-. 
bined the data originating in these locations. 
The LMR indicates that the Cuna sample population 
studied, unlike whites,' is not characterized by the pres-
ence of deficient metabolizers. This can be appreciated 
by the absence of an antimode in Fig. 1, as well as by 
the nature of the respective curve in its probit plot, as. 
shown in Fig.  2. In addition, the, highest value found 
for the metabolic ratio was 5.70 (LMR = 0.76), which 
is about three and a half times smaller than the antimode 
value in whites to whom the value of 20 (LMR = 1.3) 
has been assigned.' 
The absence of deficient metabolizers among those 
28 subjects who were excluded because of their close 
consanguinity relations further supports our belief, 
based on a total of 170 subjects studied, that the Cuna 
subjects in our sample population are not characterized 
by a group of poor metabolizers. 
0 
LOG (SP/DH) 
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Fig. 2. Probit plots of the LMR (log SP1DH) from 142 Cuna 
Amerindians and 154 Ghanaians reported by Eichelbaum and 
Woolhouse.' No significant differences (p > 0.05) were 
found by the Mann-Whitney U test. 
Absence of deficient metabolizers in the Cuna sam-
ple and its implication for the existence of polymor-
phism in this population. The existence of an inflection 
point in the probit plot shown in Fig, 2 at 6.3 probit U 
(92.5% or 7.5%) should be taken as indicative of the 
existence of at least two subgroups congregating within 
the same mode of the distribution curve. The largest 
subgroup could correspond to 92.5% of the total sub-
jects and the smallest to 7.5%. The dividing line is 
estimated to be at LMR = 0.125. Indeed, the two 
subgroups could correspond to both homozygous dom-
inants(AA) and heterozygous (Aa) subjects of the well- 
k► 	 n white phenotypes. 
Having concluded that the existence of the inflection 
point does not allow the exclusion of heterozygous (Aa) 
subjects in the Cuna population sample studied. the use 
of this point to determine the number of heterozygous 
subjects must be evaluated. To accomplish this, instead 
of using the Cuna data that present limitations for this 
purpose. because no homozygous-recessive subjects 
have been observed in our sample, one can use the 
Canadian white data shown in Fig. 1, a population in 
which they are known to exist. From the inflection point 
the number of heterozygous subjects can be estimated 
to be 5.4% of the total population, which in fact is 
lower than the 7.5% estimated for the Cunas. 
These results merit further analysis on the basis 
of comparisons between these two ethnic groups be- 
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cause they are contradictory with the existence of 
homozygous-recessive subjects (aa) or poor metabo-
lizers found in the Canadians and the absence of poor 
metabolizers in the sample studied. In fact the number 
of heterozygotes should be higher in Canadians than in 
the Cunas population at large. This point is discussed 
further in the following section. 
According to the Hardy-Weinberg law, if the fre-
quency of poor metabolizers = 71199 in the Canadian 
white (q = 0.19), the number of the estimated hetero-
zygous subjects would be 31%. There is then a very 
serious discrepancy between the values calculated by 
the Hardy-Weinberg law and those using the inflection 
point, 31% vs. 5.4%, as indicated above. This dis-
agreement weakens the validity of this approach when 
used to estimate the number of heterozygous subjects. 
This could be the result of at least one of the assump-
tions inherent in this approach (i.e., an invariable, 
precise correspondence between genotypes of the white 
type, in this case homozygous dominant (AA) and 
heterozygous (Aa), and their phenotypic expression). 
However, this assumption can be questioned as inferred 
from published works, for instance, Steiner et al.' 
(Eichelbaum, personal communication). 
The overall genetic structure of Amerindians includes 
many more monomorphormic loci and rare variants than 
in white populations, probably as a result of a more pro-
nounced genetic drift and endogamy.'"'" It is there-
fore conceivable that some of the, subjects in the smaller 
subgroup present in the single mode might carry a mu-
tant allele, as has been suggested for Ghanaians." The 
corresponding cytochrome P-450 isozyme might have 
slightly altered catalytic properties. Therefore this ten-
tative proposal entails the existence of three different 
alleles: the classic white ones, A and a, and a third 
mutant allele. The inflection point might divide the 
subjects carrying this mutant allele from the white 
homozygous-dominant and heterozygote populations. 
In conclusion, our presently available data do not 
allow us to reach conclusions regarding polymorphism 
or its absence in the Curia population at large from the-
results obtained in the Cuna population sample studied, 
for two reasons: (I) those associated with the assump-
tions inherent in the method represented by the use of 
the inflection point and (2) conflicting criteria that are 
used to determine the existence of polymorphism. 
among other things."' We intend to address these 
crucial points in a future publication. 
The Cuna and certain other ethnic groups: Cana-
dian whites and black Ghanaians. It is interesting to 
contrast the results obtained in the Cuna to those of 
Canadian whites.'"' as shown in the two histograms 
VOLIZMY 	 - 
• NUMBER. 4 Sparteine metabolism 463 
Table III. Sparteine metabolic ratios in Cuna Amerindians, black Ghanaians, and Canadian whites 
Cana Ghanaian 
Metabolic ratio log Amerindians blacks Whites Whites 
(SP/DH) (tt = 142) (n = 154)* (n = 192; EM)t = 199; EM 	 PM)t 
Mean ± SD —0.21 ± 0.26 —0.18 ± 0.36 —0.24 ± 0.40 —0.16 ± 0.56 
Median —0.24 —0.24 —0.31 —0.28 
Minimum/maximum —0.73/0.76 —0.85/1.10 —1.06/1.15 —1.0612.58 
Skewness 1.00f 0.79$ 1.0a 2.15$ 
Kurtosis 4.95§ 3.6311 4.23§ 9.41§ 
SP, *amine; OH, debydrosparteine; EM, extensive metabolizes-, PM, poor rnetabolizer. 
*Data tioni Elate/bourn and Woolhouse.' 
tCanadian data (tee Ftg. 1). 
Positive skewness (<1%. upper tail). 
OPoUtive kurtosis' (<1%, peaked distribution). 
Wei significant kurtosis (>5%). 
in Fig. 1. As a whole, the two populations are distin-
r'shable by the absence in the Curia of the group 
1.etsented by the deficient metabolizers found in this 
white population (3.5%). However, equally remarkable 
are the similarities observed for the two groups of ex-
tensive metabolizers; the distributions, although not 
quantitatively identical (mean/median, Cuna =-
0.875; white = 0.774), are suggestively similar (skew-
ness values: Cunas = 1.00; Canadian whites = 
These differences and similarities are also shown in 
Table EEL 
To the extent that these two populations are similar 
and to the degree that we have not seen deficient me-
tabolizers in the Cuna sample studied, the probable 
number of heterozygotes (Aa) in this sample should 
decrease and, thus, their contribution to one of the 
observed subgroups present in the single mode should 
also diminish. If we assume that in the Cuna population 
the frequency of poor metabolizers is similar to that 
found in Canadian whites (3.5%), the probability of 
ling all subjects extensive metabolizers in the 170 
Lams examined would be 0.0023 or, vice versa, the 
probability of not finding a poor metabolizer in 170 
subjects would be 0.0023. If we use the more com-
monly accepted figure of 5.4% of poor metabolizers in 
whites, the probability would be less than 0.0016. 
Although this is not a convincing argument per se 
and assumes certain similarities between the Cuna 
population and the largest mode of the Canadian whites, 
it reinforces our suggestion for the existence of a non-
white isozyme, as indicated above. 
The absence of deficient metabolizers is a trait that 
the Cuna share with the Ghanaians-studied by Eichel-
baum and Woolhouse.' To compare these two popula-
tions. we have presented in Fig. 2 the results of their 
study tocether with ours. The lines intersect at about a  
probit value of 5, indicating the same median and pos-
sibly the same mean values. After we calculated the 
pertinent parameters from the published data,' as shown 
in Table III, we could confirm these observations by 
the Mann-Whitney Ll test. 
Moreover, the data of the Cunas showed a steeper 
slope, indicating an even narrower distribution or less 
variability than the Ghanaians. This is consistent 
with the predominant genetic control of sparteine 
biotransformation` and the genetic homogeneity of the 
Cunas noted above, a result that is apparent from its 
very low racial admixture with respect to both non-
Amerindians and Amerindian groups. It is logical 
to expect that genetically homogeneous populations 
should show less dispersion of phenotypic character-
istics than others that are less so. In fact, these results 
are consistent with the relative homogeneity of blood 
groups found in certain African groups and Amerin-
dians.24 
The limiting values of sparteine metabolic ratio for 
these two groups also compare favorably: 0.18 to 5.70 
for the Cunas vs. 0.14 to 12.5 for the Ghanaians. Nev-
ertheless, the skewness value for the Ghanaians is 
smaller (0.79) than are those for the Cunas (1.00) and 
the white extensive metabolizers (1.01), as can be seen 
in Table III. As discussed above on the basis of the 
probit plots, there is a greater dispersion of values in 
the Ghanaians compared with the Cunas; the values of 
the Ghanaians are more symmetrically distributed about 
the man, as indicated by the skewness. 
Conclusions. The results of the present study, ap-
preciated in the light of all those carried out in nonwhite 
populations: Ghanaian blacks' and Japanese (Inaba T, 
Kalow W. personal communication), indicate that the 
frequency of deficient metabolizers of sparteine is not 
as widespread as would have been expected from the 
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results found in whites. It is therefore logical to con-
clude that the frequency of deficient metabolizers of a 
particular oxidative pathway in one population does not 
necessarily translate itself into others, or even that the 
presence of polymorphism in one ethnic group does not 
guarantee its existence in others. 
In addition, the possible existence of nonwhite-type 
isozyme variants should be kept in mind in the inves-
tigation of ethnic groups in general and the interpre-
tation of deviations from normality in unimodally dis-
tributed curves in particular. 
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